George Yancopoulos, Regeneron president and CSO (Regeneron)
Regeneron scores label expansion for cholesterol drug Evkeeza
Regeneron’s drug for a rare disease that causes high cholesterol has been expanded to include children ages 5 to 11 years old after an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
